Condition (MeSH)
Smear Layer
ClinicalTrials.gov lists 2 trials for Smear Layer or a narrower condition beneath it. Turkish Ministry of Health, Kahramanmaras Provincial Health Directorate has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section (log scale)
4 sections measured, none recorded · 1 not measured yet · 1 not computed
2 of the 2 trials are tagged with Smear Layer itself; the rest are tagged with a narrower condition beneath it.
When did Smear Layer trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2022 | 1 |
| 2015 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Smear Layer trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Not applicable | 2 |
How many Smear Layer trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Smear Layer trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Turkish Ministry of Health, Kahramanmaras Provincial Health Directorate | 1 |
Which publications cover Smear Layer? (53)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Evaluation of the efficiency of smear layer removal during endodontic treatment using scanning electron microscopy: an in vitro study. | BMC oral health | 2025 | Yes |
| Effects of phytic acid and etidronic acid using continuous and sequential chelation on the removal of smear layer, dentin microhardness, and push-out bond strength of calcium silicate-based cement. | BMC oral health | 2025 | Yes |
| Effectiveness of continuous chelation irrigation protocol in endodontics: a scoping review of laboratory studies. | Odontology | 2024 | Yes |
| In Vitro Evaluation of Smear Layer and Debris Removal and Antimicrobial Activity of Different Irrigating Solutions. | European endodontic journal | 2024 | Yes |
| Efficacy of sonic and ultrasonic activation during endodontic treatment: a Meta-analysis of <i>in vitro</i> studies. | Acta odontologica Scandinavica | 2022 | Yes |
Showing 5 of 53 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.